Walgreens Boots Alliance, Inc. (WBA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 17.81 |
| Open | 17.84 |
| Bid | 17.25 x 1900 |
| Ask | 17.28 x 1900 |
| Day's Range | 17.24 - 17.92 |
| 52 Week Range | 17.24 - 32.89 |
| Volume | |
| Avg. Volume | 11,654,971 |
| Market Cap | 14.89B |
| Beta (5Y Monthly) | 0.75 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.00 |
| Earnings Date | Jun 25, 2024 - Jul 01, 2024 |
| Forward Dividend & Yield | 1.00 (5.79%) |
| Ex-Dividend Date | May 20, 2024 |
| 1y Target Est | 20.85 |
ZacksWalgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $17.53, indicating a +1.1% shift from the previous trading day.
ACCESSWIREWalgreens and Boehringer Ingelheim Are Partnering to Improve Diversity in Clinical Trials
Joint collaborations bring Boehringer Ingelheim's Phase III clinical trial to communities through Walgreens pharmacy clinical trial centers and EmVenio's mobile research units, aimed at improving access to trials Originally published by Walgreens ...
Yahoo FinanceWalgreens partners with Boehringer Ingelheim for clinical trials
Walgreens is ramping up its clinical trial offerings with Big Pharma players.
© 2024 Yahoo. All rights reserved.